{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:08:53Z","timestamp":1790114933520,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpba.2026.117678","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:43:21Z","timestamp":1785167001000},"page":"117678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomimetic chromatographic descriptors for modeling therapeutic, toxic, and lethal blood concentration endpoints: convergence with conventional physicochemical properties"],"prefix":"10.1016","volume":"281","author":[{"given":"Chrysanthos","family":"Stergiopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117678_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1520-6017(200008)89:8<1085::AID-JPS13>3.0.CO;2-N","article-title":"Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures","volume":"89","author":"Valko","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117678_bib2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jps.10494","article-title":"Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol\/water and immobilized artificial membrane lipophilicity","volume":"92","author":"Valko","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117678_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpba.2016.04.009","article-title":"Lipophilicity and biomimetic properties measured by HPLC to support drug discovery","volume":"130","author":"Valk\u00f3","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117678_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ansa.202200004","article-title":"Biomimetic chromatography \u2013 a novel application of the chromatographic principles","volume":"3","author":"Valk\u00f3","year":"2022","journal-title":"Anal. Sci. Adv."},{"key":"10.1016\/j.jpba.2026.117678_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bmc.1130090504","article-title":"Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data","volume":"9","author":"Kaliszan","year":"1995","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2026.117678_bib6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17460441.2017.1344210","article-title":"Lipophilicity and biomimetic properties to support drug discovery","volume":"12","author":"Tsopelas","year":"2017","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.jpba.2026.117678_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpba.2012.11.034","article-title":"Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data","volume":"75","author":"Grumetto","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117678_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2017.10.022","article-title":"Structural properties governing drug-plasma protein binding determined by high-performance liquid chromatography method","volume":"149","author":"Kamble","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117678_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpba.2005.11.011","article-title":"Molecular lipophilicity determination of a huperzine series by HPLC: comparison of C18 and IAM stationary phases","volume":"41","author":"Darrouzain","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117678_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpba.2015.12.015","article-title":"High-throughput logPo\/w determination from UHPLC measurements: revisiting the chromatographic hydrophobicity index","volume":"127","author":"Subirats","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117678_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.jpba.2026.117678_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.jpba.2026.117678_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2026.117678_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.jpba.2026.117678_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1009935116877","article-title":"Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs","volume":"15","author":"Regenthal","year":"1999","journal-title":"J. Clin. Monit. Comput."},{"key":"10.1016\/j.jpba.2026.117678_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s12024-023-00709-z","article-title":"Postmortem redistribution of drugs: a literature review","volume":"20","author":"Abdelaal","year":"2024","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.jpba.2026.117678_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.12793\/tcp.2018.26.4.150","article-title":"Pharmacodynamic principles and target concentration intervention","volume":"26","author":"Holford","year":"2018","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2026.117678_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","article-title":"Best practices for QSAR model development, validation, and exploitation","volume":"29","author":"Tropsha","year":"2010","journal-title":"Mol. Inform."},{"key":"10.1016\/j.jpba.2026.117678_bib19","doi-asserted-by":"crossref","unstructured":"OECD, Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models, OECD Series on Testing and Assessment, No. 69, OECD Publishing, Paris (2014). https:\/\/doi.org\/10.1787\/9789264085442-en.","DOI":"10.1787\/9789264085442-en"},{"key":"10.1016\/j.jpba.2026.117678_bib20","doi-asserted-by":"crossref","unstructured":"OECD, (Q)SAR Assessment Framework: Guidance for the Regulatory Assessment of (Quantitative) Structure Activity Relationship Models and Predictions, OECD Series on Testing and Assessment, No. 386, OECD Publishing, Paris (2023). https:\/\/doi.org\/10.1787\/d96118f6-en.","DOI":"10.1787\/d96118f6-en"},{"key":"10.1016\/j.jpba.2026.117678_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/096032718300200301","article-title":"A collection of therapeutic, toxic and fatal blood drug concentrations in man","volume":"2","author":"Stead","year":"1983","journal-title":"Hum. Toxicol."},{"key":"10.1016\/j.jpba.2026.117678_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.forsciint.2004.02.017","article-title":"Fatal blood and tissue concentrations of more than 200 drugs","volume":"142","author":"Musshoff","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2026.117678_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","article-title":"Drug and chemical blood-level data 2001","volume":"122","author":"Winek","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2026.117678_bib24","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1021\/jo049766y","article-title":"Determination of solvation descriptors for ionic species: hydrogen bond acidity and basicity","volume":"69","author":"Abraham","year":"2004","journal-title":"J. Org. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:45:58Z","timestamp":1790113558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526003468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S0731708526003468"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117678","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic chromatographic descriptors for modeling therapeutic, toxic, and lethal blood concentration endpoints: convergence with conventional physicochemical properties","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117678"}}